Loading…

Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy study

Although many anti-diabetic drugs have been used to control hyperglycemia for decades, the efficacy of commonly-used oral glucose-lowering agents in Korean type 2 diabetic patients has yet to be clearly demonstrated. We evaluated the efficacy of glimepiride, metformin, and rosiglitazone as initial t...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes & metabolism journal 2011, 35(1), 123, pp.26-33
Main Authors: Yoon, Kun Ho, Shin, Jeong Ah, Kwon, Hyuk Sang, Lee, Seung Hwan, Min, Kyung Wan, Ahn, Yu Bae, Yoo, Soon Jib, Ahn, Kyu Jeung, Park, Sung Woo, Lee, Kwan Woo, Sung, Yeon Ah, Park, Tae Sun, Kim, Min Seon, Kim, Yong Ki, Nam, Moon Suk, Kim, Hye Soon, Park, Ie Byung, Park, Jong Suk, Woo, Jeong Taek, Son, Ho Young
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although many anti-diabetic drugs have been used to control hyperglycemia for decades, the efficacy of commonly-used oral glucose-lowering agents in Korean type 2 diabetic patients has yet to be clearly demonstrated. We evaluated the efficacy of glimepiride, metformin, and rosiglitazone as initial treatment for drug-naïve type 2 diabetes mellitus patients in a 48-week, double-blind, randomized controlled study that included 349 Korean patients. Our primary goal was to determine the change in HbA1c levels from baseline to end point. Our secondary goal was to evaluate changes in fasting plasma glucose (FPG) levels, body weight, frequency of adverse events, and the proportion of participants achieving target HbA1c levels. HbA1c levels decreased from 7.8% to 6.9% in the glimepiride group (P
ISSN:2233-6079
2233-6087
DOI:10.4093/dmj.2011.35.1.26